Literature DB >> 15622455

Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development.

Sandra A Koesters1, Lucy Matu, Peter Kiama, Omu Anzala, Joanne Embree, Francis A Plummer, Joshua Kimani, Keith R Fowke.   

Abstract

The infectious burden leading to immune activation can vary between different populations and lead to various immune dysfunctions. We compared the effect of immune activation on apoptosis and T cell function in HIV uninfected individuals from Nairobi, Kenya (n=34), and Winnipeg, Canada (n=10). Women from Nairobi had a significantly greater number of CD8+ T cells expressing the activation markers CD38 and HLA DR. Kenyan women also had significantly higher levels of CTLA-4+ CD4 and CD8+ T cells, and reduced levels of CD28+ CD8+ cells. Levels of CD95+ CD4+ T cells were higher in Kenyan women and, correspondingly, showed higher levels of spontaneous apoptosis. Kenyan women also demonstrated hyper-responsiveness to T cell activation as assessed by interferon gamma production. This study demonstrates that in a population of Kenyan women with high levels of T cell activation, there were also elevated levels of T cell apoptotic death and hyper-responsiveness. These differences may influence the efficacy of immune responses to pathogens and must be considered when testing candidate vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15622455     DOI: 10.1007/s10875-004-6238-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.

Authors:  T Messele; M Abdulkadir; A L Fontanet; B Petros; D Hamann; M Koot; M T Roos; P T Schellekens; F Miedema; T F Rinke de Wit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 2.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 3.  Premature ageing of the immune system: the cause of AIDS?

Authors:  Victor Appay; Sarah L Rowland-Jones
Journal:  Trends Immunol       Date:  2002-12       Impact factor: 16.687

4.  [Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations?].

Authors:  Ursula Hainz; Kurt Aigner; Esther Asch; Peter Berger; Franz Böhmer; Bruno Feldkircher; Brigitte Horwath; Brigitte Jenewein; Hermann Kassal; Otfried Kistner; Hans Mack; Karl-Peter Pfeiffer; Katharina Pils; Johannes Plank; Doris Renner; Maria Saurwein-Teissl; Erhard Schwanzer; Klemens Trieb; Beatrix Grubeck-Loebenstein
Journal:  Wien Klin Wochenschr       Date:  2002-03-28       Impact factor: 1.704

Review 5.  Immune activation in the context of HIV infection.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; Z Grossman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 6.  Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells.

Authors:  R Tarazona; O DelaRosa; C Alonso; B Ostos; J Espejo; J Peña; R Solana
Journal:  Mech Ageing Dev       Date:  2000-12-20       Impact factor: 5.432

Review 7.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

8.  Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals.

Authors:  G Rizzardini; S Piconi; S Ruzzante; M L Fusi; M Lukwiya; S Declich; M Tamburini; M L Villa; M Fabiani; F Milazzo; M Clerici
Journal:  AIDS       Date:  1996-11       Impact factor: 4.177

9.  A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients.

Authors:  Sisse R Ostrowski; Jan Gerstoft; Bente K Pedersen; Henrik Ullum
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

10.  Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes.

Authors:  Robert C Kalayjian; Alan Landay; Richard B Pollard; Dennis D Taub; Barry H Gross; Isaac R Francis; Anne Sevin; Minya Pu; John Spritzler; Miriam Chernoff; Ann Namkung; Lawrence Fox; Ana Martinez; Karen Waterman; Susan A Fiscus; Beverly Sha; Debra Johnson; Stanley Slater; Frank Rousseau; Michael M Lederman
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

View more
  10 in total

Review 1.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 2.  Inflammation and HIV Transmission in Sub-Saharan Africa.

Authors:  Rupert Kaul; Jessica Prodger; Vineet Joag; Brett Shannon; Sergey Yegorov; Ronald Galiwango; Lyle McKinnon
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

3.  Clade A HIV-1 Gag-specific T cell responses are frequent but do not correlate with viral loads in a cohort of treatment-naive HIV-infected individuals living in Guinea-Bissau.

Authors:  Kristoffer Jarlov Jensen; Victor Raúl Gómez Román; Sanne Skov Jensen; Christian Leo-Hansen; Ingrid Karlsson; Terese Lea Katzenstein; Candida Medina Rodrigues; Sanne Jespersen; Christoph Mikkel Janitzek; David da Silva Té; Peter Hayes; Anders Fomsgaard
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

Review 4.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

5.  Activation and maturation of peripheral blood T cells in HIV-1-infected and HIV-1-uninfected adults in Burkina Faso: a cross-sectional study.

Authors:  Hans-Georg Kräusslich; Thomas Böhler; Fabrice Tiba; Frans Nauwelaers; Lassana Sangaré; Boubacar Coulibaly
Journal:  J Int AIDS Soc       Date:  2011-12-17       Impact factor: 5.396

6.  Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Authors:  Jennifer A Juno; Andrew T Stalker; Jillian Lm Waruk; Julius Oyugi; Makobu Kimani; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  Retrovirology       Date:  2015-02-13       Impact factor: 4.602

7.  The Impact of Sex Work Interruption on Blood-Derived T Cells in Sex Workers from Nairobi, Kenya.

Authors:  Kenneth Omollo; Geneviève Boily-Larouche; Julie Lajoie; Makobu Kimani; Julianna Cheruiyot; Joshua Kimani; Julius Oyugi; Keith Raymond Fowke
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-16       Impact factor: 2.205

8.  High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Authors:  Amy Y Liu; Stephen C De Rosa; Brandon L Guthrie; Robert Y Choi; Rose Kerubo-Bosire; Barbra A Richardson; James Kiarie; Carey Farquhar; Barbara Lohman-Payne
Journal:  Immun Inflamm Dis       Date:  2018-07-04

9.  Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway.

Authors:  Seema M Thayil; Ya-Chi Ho; Robert C Bollinger; Joel N Blankson; Robert F Siliciano; Petros C Karakousis; Kathleen R Page
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.